Semax

Cognition, Mood & Neuroprotection
Preclinical
Russia Approved

Semax is a synthetic peptide derived from a brain hormone fragment (ACTH 4-10), developed in Russia for brain-protective and cognitive-enhancing purposes. Research focuses on stroke recovery, cognitive function, and brain growth factor support.

Last updated February 22, 2026
181 PubMed-Verified Studies
Very Popular
Research-Driven Dosage Reports
RouteIntranasal · Subcutaneous (SC)
Dose200–600 mcg
Frequency1–3× daily (intranasal)
Duration2–8 weeks

Based on published research literature.

Swiss Chems|Exclusive Offer
Coupon
10%
Off

Use our affiliate link and code PEPTIDEWIKI at checkout to unlock your 10% discount, every time you use the code.

Shop Now

For research purposes only. PeptideWiki may earn a commission at no extra cost to you.

Overview of Semax

Rapidly upregulates BDNF and TrkB receptor expression, modulates neurotransmission genes, and influences serotonergic and dopaminergic pathways.

Neuro / cognition

Rapidly increases Brain-Derived Neurotrophic Factor and TrkB receptor expression in hippocampus, enhancing neuroplasticity and memory.

Affects over 1,500 genes in stroke models, suppressing inflammation-related genes while activating neurotransmission and immune system genes.

Activates serotonergic and dopaminergic pathways (proposed), which may interact with melanocortin receptors, specifically MC4R (proposed).

Neuroprotection

Reduces infarction size and improves neurological function in stroke models, increasing plasma BDNF in patients.

Forms stable complexes with copper ions (proposed), which may prevent copper-induced amyloid-beta aggregation (Alzheimer's research)

Read Full Semax Dosage Guide

Research-backed dosing protocols, timing, and administration details

Browse more in this category

Cognition, Mood & Neuroprotection

Related Articles